Cytodyn Inc (CYDY)

[Saltz]

Misiu,
Thank you for your insight. You are a valuable asset to this community.

Can you address the complication with the profile and requirements for the 30 patients needed to complete the P3 Adjunct Trial. I find it interesting that in early January Nader announced that 7 patients had completed the P3 Adjunct and were going on the extension study. That would seem to be really good news. I mean that means that they had completed the entire study before enrollment was complete. You are correct as it seems clear that Pro-140 meets all of the criteria for BTD.

What I'm asking is for you to add some clarity as to the lag time to complete enrollment and what your thoughts are if we are given another delay to complete enrollment. I ask this because it is quite possible that the $ amount of the last raise was determined by time needed to complete Adjunct P3 PE which may be pushed back.

In the future I would hope that no poster cause you to go silent. You are needed Misiu.